Business Description
Gemina Laboratories Ltd
NAICS : 541713
SIC : 3741
ISIN : CA3686501071
Description
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.17 | |||||
| Equity-to-Asset | -1.77 | |||||
| Debt-to-Equity | -0.45 | |||||
| Debt-to-EBITDA | -0.34 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.38 | |||||
| 9-Day RSI | 48.66 | |||||
| 14-Day RSI | 49.78 | |||||
| 6-1 Month Momentum % | 58.86 | |||||
| 12-1 Month Momentum % | 84.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.09 | |||||
| Quick Ratio | 0.09 | |||||
| Cash Ratio | 0.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.52 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -234.54 | |||||
| ROIC % | -190.12 | |||||
| ROC (Joel Greenblatt) % | -1079.31 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -11.19 | |||||
| EV-to-EBITDA | -11.53 | |||||
| EV-to-FCF | -29.98 | |||||
| Earnings Yield (Greenblatt) % | -8.94 | |||||
| FCF Yield % | -3.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:GLABF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gemina Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.036 | ||
| Beta | 0 | ||
| Volatility % | 107.84 | ||
| 14-Day RSI | 49.78 | ||
| 14-Day ATR ($) | 0.025983 | ||
| 20-Day SMA ($) | 0.50866 | ||
| 12-1 Month Momentum % | 84.98 | ||
| 52-Week Range ($) | 0.235 - 0.6504 | ||
| Shares Outstanding (Mil) | 74.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gemina Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gemina Laboratories Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gemina Laboratories Ltd Frequently Asked Questions
What is Gemina Laboratories Ltd(GLABF)'s stock price today?
The current price of GLABF is $0.46. The 52 week high of GLABF is $0.65 and 52 week low is $0.24.
When is next earnings date of Gemina Laboratories Ltd(GLABF)?
The next earnings date of Gemina Laboratories Ltd(GLABF) is .
Does Gemina Laboratories Ltd(GLABF) pay dividends? If so, how much?
Gemina Laboratories Ltd(GLABF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers